Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Shattuck Labs, Inc. (STTK) Investigation
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK). Investors who purchased Shattuck shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/sttk.
The investigation concerns whether Shattuck and certain of its officers and/or directors have violated federal securities laws.
On November 9, 2021, Shattuck announced its financial results for the third quarter of 2021 and corporate updates, including that, "[i]n November 2021, Shattuck and Takeda [Pharmaceutical Company Limited] mutually agreed to termination of the Collaboration Agreement for SL-279252 and SL-115154, originally executed in 2017. Shattuck is no longer required to satisfy any remaining performance obligations, the Company will not make any payments to or receive any future milestone or royalty payments from Takeda, and all options to license and rights of first negotiation held by Takeda under the Collaboration Agreement were terminated." Additionally, Shattuck announced a new chairman to its Company's Board of Directors. Following this news, Shattuck stock dropped $5.45 per share, or 28%, to close at $13.59 on November 9, 2021.
If you are aware of any facts relating to this investigation or purchased Shattuck shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/sttk. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/674150/Bronstein-Gewirtz-Grossman-LLC-Notifies-Shareholders-of-Shattuck-Labs-Inc-STTK-Investigation
